Board of Pharmacy Specialties
2215 Constitution Avenue, NW
Washington, DC 20037
(202) 429-7591
(202) 429-6304 FAX
www.bpsweb.org
FOR IMMEDIATE RELEASE:
May 2, 2011
Contact:
Ryan Abel
info@bpsweb.org
202-429-6306
BPS Issues Call for Members of the Critical Care Pharmacy and Pediatric Pharmacy Practice Analysis Taskforces
During the BPS Board meeting held on April 9, 2011, the Board reviewed the preliminary request to consider two new specialties: Critical Care Pharmacy and Pediatric Pharmacy. BPS will move forward with conducting role delineation studies for each of these proposed specialties. Conducting a role delineation study is a critical step in evaluating a proposed specialty. The purpose of these role delineation studies is to determine whether Critical Care Pharmacy and Pediatric Pharmacy are based upon a specialized knowledge of the pharmaceutical sciences as well as specialized functions routinely performed by practitioners in these proposed specialties.
To begin moving forward with the role delineation studies in Critical Care Pharmacy and Pediatric Pharmacy, BPS will need the following:
- Names and resumes of subject matter experts in the areas of Critical Care Pharmacy and Pediatric Pharmacy; (8 to 10 individuals will be selected to serve on each Practice Analysis Task Force). However, in addition to these Task Forces, additional subject matter experts can assist BPS by participating in a telephone interview, an e-mail–based external review of documents developed by the relevant Task Force, or the pilot test of the related survey. The link to the Call for Nominations is below and self-nominations are welcomed from subject matter experts.
For Critical Care Pharmacy — https://www.surveymonkey.com/s/BPSCC
For Pediatric Pharmacy — https://www.surveymonkey.com/s/BPSPed
Due Date for both Critical Care Pharmacy and Pediatric Pharmacy Nominations: June 8, 2011
BPS will announce the appointments on or about June 17, 2011. - BPS will convene a 2-day meeting with the Critical Care Pharmacy Practice Analysis Task Force on July 26-27, 2011, in Washington, DC, to create a preliminary content outline for this proposed specialty. Attendance by appointees to the Critical Care Pharmacy Practice Analysis Taskforce at this meeting is required. If you cannot attend this meeting and would like to be involved, please volunteer for one of the other activities outlined in the link above.
- BPS will then convene a 2-day meeting with the Pediatric Pharmacy Practice Analysis Task Force on August 2-3, 2011, in Washington, DC, to create a preliminary content outline for this proposed specialty. Attendance by appointees to the Pediatric Pharmacy Practice Analysis Taskforce at this meeting is required. If you cannot attend this meeting and would like to be involved, please volunteer for one of the other activities outlined in the link above.
About the Board of Pharmacy Specialties
The Board of Pharmacy Specialties (BPS) is an autonomous Division of the American Pharmacists Association (APhA), founded in January 1976 to recognize specialties and certify pharmacists in specialized areas of pharmacy practice. Six specialties are currently recognized by BPS, including: 1) nuclear pharmacy, since 1978; 2) nutrition support pharmacy, since 1988; 3) pharmacotherapy, since 1988; 4) psychiatric pharmacy, since 1992; and 5) oncology pharmacy, since 1996. The latest BPS specialty, focused on ambulatory care pharmacy, was approved in June 2009, and is scheduled for its first examination in October. More than 10,450 pharmacist specialists are currently certified by BPS.
